1. Background
2. Objectives
3. Methods
3.1. Study Population
3.2. Study Procedure
3.3. Statistical Analysis
4. Results
4.1. Clinical Features and Characteristics of Patients
| Variables | Total (n = 94) | Positive CNS Infection | Negative CNS Infection (n = 46) | P-Value | |
|---|---|---|---|---|---|
| Bacterial (n = 11) | Viral (n = 37) | ||||
| (A) Patients’ characteristics | |||||
| Gender | 0.49 | ||||
| Male | 54 (57.4) | 5 (45.5) | 20 (54.0) | 29 (63.0) | |
| Feeding in the first-year | 0.87 | ||||
| Breastfeeding | 72 (76.6) | 9 (81.8) | 29 (78.4) | 34 (74.0) | |
| Formula | 5 (5.3) | 1 (9.1) | 2 (5.4) | 2 (4.3) | |
| Both | 17 (18.1) | 1 (9.1) | 6 (16.2) | 10 (21.7) | |
| Attending school | 17 (18.1) | 1 (9.1) | 9 (24.3) | 7 (15.2) | 0.41 |
| Exposed to sick person | 10 (10.6) | 0 | 9 (24.3) | 1 (2.2) | 0.03 b |
| Secondhand smoke | 18 (19.1) | 3 (27.3) | 11 (29.7) | 4 (8.7) | 0.38 |
| Maternal education | 0.34 | ||||
| Illiterate | 9 (9.6) | 0 (0) | 5 (13.5) | 4 (8.7) | |
| School | 56 (59.6) | 7 (63.6) | 22 (59.5) | 27 (58.7) | |
| University | 29 (30.8) | 4 (36.4) | 10 (27.0) | 15 (32.6) | |
| (B) Signs of patients | |||||
| Tachy/bradycardia | 36 (38.3) | 4 (36.4) | 18 (48.6) | 14 (30.4) | 0.23 |
| Tachy/bradypnea | 36 (38.3) | 5 (45.5) | 16 (43.24) | 15 (32.6) | 0.51 |
| CRT > 2 Seconds | 2 (2.1) | 0 | 1 (2.7) | 1 (2.2) | 0.86 |
| Hypoxia | 14 (14.9) | 3 (27.3) | 5 (13.5) | 6 (13.0) | 0.54 |
| Neck rigidity, Kernig, Brudzinski | 25 (26.6) | 6 | 12 | 7 | 0.13 |
| Weakness, fatigue | 8 (8.5) | 1 (9.1) | 6 (16.2) | 1 (2.2) | 0.08 |
| Skin rash | 22 (23.4) | 2 (18.2) | 6 (16.2) | 14 (30.4) | 0.28 |
| Respiratory tract infection signs | 12 (12.76) | 2 (18.2) | 5 (13.5) | 5 (10.9) | 0.77 |
Abbreviations: CNS, central nervous system; CRT, cardiac resynchronization therapy.
a Values are expressed as No. (%).
b Indicates significant difference. Use of the chi-square statistical test.
4.2. Blood and Cerebrospinal Fluid Analysis
| Variables | Total (n = 94) | Positive CNS Infection | Negative CNS Infection (n = 46) | P-Value | |
|---|---|---|---|---|---|
| Bacterial (n = 11) | Viral (n = 37) | ||||
| (A) Blood analysis | |||||
| WBC | 11391 ± 5635 | 16936 ± 6753 | 10480 ± 4793 | 10778 ± 5324 | 0.008 b |
| PMN | 53.98 | 59.63 | 51.44 | 54.63 | 0.520 |
| Lymphocytes | 37.43 | 30.81 | 39.69 | 37.25 | 0.442 |
| Platelets | 324944 ± 148461 | 352818 ± 83537 | 326200 ± 143183 | 317323 ± 165167 | 0.541 |
| ESR | 31.83 ± 26.50 | 49.00 ± 36.48 | 30.62 ± 24.94 | 28.65 ± 23.90 | 0.147 |
| (B) CSF analysis | |||||
| WBC | 164 ± 688 | 1168 ± 1754 | 66 ± 133 | 2.5 ± 8.5 | < 0.001 b |
| PMN | 25 | 71 | 25 | 15 | < 0.001 b |
| Lymphocytes | 20 | 28 | 34 | 6.4 | < 0.001 b |
| Protein | 40.30 ± 53.14 | 89.00 ± 58.48 | 50.90 ± 65.09 | 19.21 ± 23.04 | < 0.001 b |
| Glucose | 54.61 ± 17.62 | 39.00 ± 21.21 | 54.33 ± 18.18 | 58.56 ± 14.21 | 0.01 b |
Abbreviations: WBC, white blood cells; PMNs, polymorphonuclear neutrophils; ESR, erythrocyte sedimentation rate; CRP, c-reactive protein; CSF, cerebrospinal fluid.
a Values are expressed as (%) or mean ± SD.
b Indicates significant difference. Use of the Mann-Whitney test.
4.3. Molecular Analysis
| Viral Types | Frequency (n = 37) | Bacterial Types | Frequency (n = 11) |
|---|---|---|---|
| Enterovirus | 16 (43.2) | Gram-negative cocci | 2 (18.1) |
| Herpes simplex virus | 10 (27.0) | Gram-positive cocci | 5 (45.5) |
| Mumps | 2 (5.4) | Burkholderia | 1 (9.1) |
| Varicella zoster virus | 3 (8.1) | Salmonella typhi | 1 (9.1) |
| Epstein–Barr virus | 6 (16.2) | Brucellosis | 1 (9.1) |
| Adenovirus | 0 | Citrobacter | 1 (9.1) |
| Influenza viruses | 0 | - | - |
a Values are expressed as No. (%).
4.4. Imaging Studies
4.5. Patient Monitoring
| Variables | Positive CNS Infection | Negative CNS Infection (n = 46) | P–Value b | P–Value c | ||
|---|---|---|---|---|---|---|
| Bacterial (n = 11) | Viral (n = 37) | |||||
| (A) Comparison Analysis | ||||||
| PedsQL total | 16.54 ± 21.54 | 22.48 ± 21.98 | 11.82 ± 15.94 | 0.047 d | 0.020 d | |
| ADHD positive | 5 (45.5) | 12 (32.4) | 13 (28) | 0.553 | 0.251 | |
| Abnormal neurological examination | 2 (18.2) | 15 (40.5) | 7 (15.2) | 0.028 d | 0.033 d | |
| Seizure | 4 (36.4) | 18 (48.6) | 13 (28.3) | 0.161 | 0.077 | |
| Abnormal imaging | 4 (36.4) | 17 (45.9) | 0 (0) | < 0.001 d | < 0.001 d | |
| (B) Univariate Logistic Regression Analysis | ||||||
| Variables and Group | OR | CI | P-Value | |||
| ADHD positive | ||||||
| Negative CNS (ref) | 1 | - | - | |||
| Viral | 1.066 | 0.865 - 1.313 | 0.547 | |||
| Bacterial | 1.180 | 0.867 - 1.607 | 0.293 | |||
| Positive CNS | 1.093 | 0.900 - 1.327 | 0.369 | |||
| PedsQL (upper 25th percentile) | ||||||
| Negative CNS (ref) | 1 | - | - | |||
| Viral | 1.270 | 1.050 - 1.534 | 0.014 d | |||
| Bacterial | 1.270 | 0.928 - 1.737 | 0.136 | |||
| Positive CNS | 3.800 | 1.300 - 11.110 | 0.015 d | |||
| Seizure | ||||||
| Negative CNS (ref) | 1 | - | - | |||
| Viral | 2.405 | 0.968 - 5.972 | 0.059 | |||
| Bacterial | 1.451 | 0.363 - 5.801 | 0.599 | |||
| Positive CNS | 1.148 | 0.912 - 5.060 | 0.080 | |||
| Abnormal neurological examination | ||||||
| Negative CNS (ref) | 1 | - | - | |||
| Viral | 3.799 | 1.345 - 10.729 | 0.012 d | |||
| Bacterial | 1.238 | 0.219 - 6.988 | 0.809 | |||
| Positive CNS | 3.055 | 1.126 - 8.293 | 0.028 | |||
Abbreviations: ADHD, attention deficit-hyperactivity disorder; CNS, central nervous system.
a Values are expressed as No. (%), mean ± SD unless otherwise indicated.
b Comparison of groups viral, bacterial, and negative CNS.
c Comparison of groups positive and negative CNS.
d Indicate significant difference. Use of statistical test.
